AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 182 filers reported holding AXSOME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,504,000 | -54.6% | 21,515 | -53.3% | 0.00% | -50.0% |
| Q2 2023 | $3,312,000 | +169.7% | 46,091 | +131.6% | 0.00% | +300.0% |
| Q1 2023 | $1,228,000 | -13.5% | 19,904 | +8.1% | 0.00% | -50.0% |
| Q4 2022 | $1,420,000 | +14.6% | 18,406 | -33.6% | 0.00% | 0.0% |
| Q3 2022 | $1,239,000 | -5.5% | 27,707 | -19.0% | 0.00% | +100.0% |
| Q2 2022 | $1,311,000 | -19.3% | 34,227 | -12.9% | 0.00% | 0.0% |
| Q1 2022 | $1,625,000 | +63.5% | 39,274 | +49.3% | 0.00% | 0.0% |
| Q4 2021 | $994,000 | +14.9% | 26,299 | +0.2% | 0.00% | 0.0% |
| Q3 2021 | $865,000 | -48.0% | 26,245 | +6.5% | 0.00% | 0.0% |
| Q2 2021 | $1,662,000 | +35.3% | 24,637 | +13.6% | 0.00% | -50.0% |
| Q1 2021 | $1,228,000 | -20.4% | 21,691 | +14.5% | 0.00% | 0.0% |
| Q4 2020 | $1,543,000 | +1759.0% | 18,940 | +1521.6% | 0.00% | – |
| Q3 2020 | $83,000 | -13.5% | 1,168 | 0.0% | 0.00% | – |
| Q2 2020 | $96,000 | – | 1,168 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
| Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
| WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
| MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
| RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
| RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
| Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
| Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
| Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |